ATE375806T1 - Verbesserungen in oder bezüglich zu kontrastmittel - Google Patents

Verbesserungen in oder bezüglich zu kontrastmittel

Info

Publication number
ATE375806T1
ATE375806T1 AT99918133T AT99918133T ATE375806T1 AT E375806 T1 ATE375806 T1 AT E375806T1 AT 99918133 T AT99918133 T AT 99918133T AT 99918133 T AT99918133 T AT 99918133T AT E375806 T1 ATE375806 T1 AT E375806T1
Authority
AT
Austria
Prior art keywords
dispersed
gas
preparations
perfusion
material present
Prior art date
Application number
AT99918133T
Other languages
German (de)
English (en)
Inventor
Morten Eriksen
Helge Tolleshaug
Roald Skurtveit
Alan Cuthbertson
Jonny Ostensen
Sigmund Frigstad
Pal Rongved
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE375806T1 publication Critical patent/ATE375806T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99918133T 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel ATE375806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents

Publications (1)

Publication Number Publication Date
ATE375806T1 true ATE375806T1 (de) 2007-11-15

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918133T ATE375806T1 (de) 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel

Country Status (17)

Country Link
US (1) US20040146462A1 (enExample)
EP (1) EP1073473B1 (enExample)
JP (1) JP2002512206A (enExample)
KR (1) KR20010042915A (enExample)
CN (1) CN1306442A (enExample)
AT (1) ATE375806T1 (enExample)
AU (1) AU3617299A (enExample)
BR (1) BR9909822A (enExample)
CA (1) CA2329175A1 (enExample)
DE (1) DE69937341D1 (enExample)
GB (1) GB9808599D0 (enExample)
HU (1) HUP0102878A3 (enExample)
IL (1) IL139147A0 (enExample)
NO (1) NO20005250L (enExample)
PL (1) PL343464A1 (enExample)
WO (1) WO1999053963A1 (enExample)
ZA (1) ZA200005789B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
KR101280760B1 (ko) 2002-11-29 2013-07-05 지이 헬스케어 에이에스 초음파 조영 물질
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
WO2004069284A2 (en) 2003-02-04 2004-08-19 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP5513708B2 (ja) * 2003-12-22 2014-06-04 ブラッコ・シュイス・ソシエテ・アノニム 造影イメージング用の気体封入マイクロベシクル・アセンブリー
EP1696965B1 (en) * 2003-12-22 2014-12-10 Bracco Suisse SA Assembly of gas-filled microvesicle with active component for contrast imaging
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
EP2247314A4 (en) * 2008-02-01 2013-11-27 Univ Boston CATIONIC CONTRASTING AGENTS AND METHOD FOR THEIR USE
AU2009241762B2 (en) * 2008-05-02 2015-07-16 Celsense Inc. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
EP3049117B1 (en) 2013-09-27 2022-07-27 Exact Therapeutics As Ultrasound mediated delivery of drugs
WO2015091414A2 (de) * 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte piperidinyl-tetrahydrochinoline
CN110913769A (zh) * 2017-07-09 2020-03-24 利兰斯坦福初级大学董事会 利用频谱合成来减少斑点的超声成像
CA3074629A1 (en) * 2017-09-07 2019-03-14 Imbiotechnologies Ltd. Sono-responsive embolic agents
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
CN114760989A (zh) 2019-10-25 2022-07-15 精准医疗股份有限公司 胰腺癌的治疗
GB2595513B (en) * 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422B (en) 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2629999B (en) 2021-04-21 2025-03-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
CN113598820B (zh) * 2021-08-18 2025-09-23 南京超微影医疗科技有限公司 超声成像方法及装置
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose
CN116271187B (zh) * 2023-03-21 2025-07-04 湖北科技学院 双模态显影温敏Pickering乳液介入栓塞材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
EP0711179B2 (en) * 1993-07-30 2010-09-01 IMCOR Pharmaceutical Co. Stabilized microbubble compositions for ultrasound
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69738406T2 (de) * 1996-10-21 2008-12-04 Ge Healthcare As Verbesserungen in oder an Kontrastmitteln
WO1998018497A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents
WO1998018498A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents

Also Published As

Publication number Publication date
ZA200005789B (en) 2001-07-30
IL139147A0 (en) 2001-11-25
NO20005250L (no) 2000-12-18
KR20010042915A (ko) 2001-05-25
CA2329175A1 (en) 1999-10-28
PL343464A1 (en) 2001-08-13
US20040146462A1 (en) 2004-07-29
HUP0102878A2 (hu) 2002-03-28
HUP0102878A3 (en) 2002-12-28
AU3617299A (en) 1999-11-08
EP1073473B1 (en) 2007-10-17
GB9808599D0 (en) 1998-06-24
CN1306442A (zh) 2001-08-01
DE69937341D1 (de) 2007-11-29
BR9909822A (pt) 2000-12-19
EP1073473A1 (en) 2001-02-07
JP2002512206A (ja) 2002-04-23
WO1999053963A1 (en) 1999-10-28
NO20005250D0 (no) 2000-10-19

Similar Documents

Publication Publication Date Title
DE69937341D1 (de) Verbesserungen in oder bezüglich zu kontrastmittel
WO1998017324A3 (en) Improvements in or relating to contrast agents
WO2004017907A3 (en) Blood clot-targeted nanoparticles
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
ES2157344T3 (es) Pirrolo(2,3-d)pirimidinas y su uso.
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
EP0966456A4 (en) THE ACTIVE SUBSTANCE RESISTANCE IN CANCER CHEMOTHERAPY REVERSING TAXOIDS AND PHARMACEUTICAL PREPARATIONS THEREOF
NO961363D0 (no) Nytt emulsjonspreparat
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
Siim et al. Scintigraphic imaging of the hypoxia marker 99mtechnetium-labeled 2, 2′-(1, 4-diaminobutane) bis (2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; Prognox): noninvasive detection of tumor response to the antivascular agent 5, 6-dimethylxanthenone-4-acetic acid
CA2383600A1 (en) Method for determining viability of a myocardial segment
KR960703597A (ko) 아폽토시스 및 관련 상태의 치료방법(methods of treating apoptosis and associated conditions)
JP2001515053A (ja) 造影剤におけるまたは造影剤に関する改良
SE9402880D0 (sv) New peptide derivatives
Tsuru et al. Characterization of histamine receptors in isolated rabbit veins.
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
GB9808582D0 (en) Improvements in or relating to contrast agents
Møller et al. Neurohumoral fluid regulation in chronic liver disease
EA200101106A1 (ru) Фармацевтический комплекс
RU2000100373A (ru) Природные противоопухолевые или противовирусные вещества и их применение
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
MX9205527A (es) Uso de 14-aminoesteroides para disminuir la velocidad de progrecion de daños estructurales al miocardio caracteristicos de la insuficiencia cardiaca congestiva
Glover et al. Myocardial uptake of Tc-99m-NOET during adenosine hyperemia in dogs with mild to moderate coronary stenoses
Khaw et al. A novel antimyosin immunoliposome treatment for preservation of dying myocytes: Tritiated thymidine uptake studies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties